Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Role of EP2 and EP4 receptor-selective agonists of prostaglandin E(2) in acute and chronic kidney failure.

Vukicevic S, Simic P, Borovecki F, Grgurevic L, Rogic D, Orlic I, Grasser WA, Thompson DD, Paralkar VM.

Kidney Int. 2006 Sep;70(6):1099-106. Epub 2006 Jul 26.

2.

Activation of EP4 receptors contributes to prostaglandin E2-mediated stimulation of renal sensory nerves.

Kopp UC, Cicha MZ, Nakamura K, Nüsing RM, Smith LA, Hökfelt T.

Am J Physiol Renal Physiol. 2004 Dec;287(6):F1269-82. Epub 2004 Aug 3.

PMID:
15292051
3.
4.

Regulation of TNFalpha and interleukin-10 production by prostaglandins I(2) and E(2): studies with prostaglandin receptor-deficient mice and prostaglandin E-receptor subtype-selective synthetic agonists.

Shinomiya S, Naraba H, Ueno A, Utsunomiya I, Maruyama T, Ohuchida S, Ushikubi F, Yuki K, Narumiya S, Sugimoto Y, Ichikawa A, Oh-ishi S.

Biochem Pharmacol. 2001 May 1;61(9):1153-60.

PMID:
11301049
5.

Involvement of endogenous prostaglandin E2 in tubular epithelial regeneration through inhibition of apoptosis and epithelial-mesenchymal transition in cisplatin-induced rat renal lesions.

Yamamoto E, Izawa T, Juniantito V, Kuwamura M, Sugiura K, Takeuchi T, Yamate J.

Histol Histopathol. 2010 Aug;25(8):995-1007. doi: 10.14670/HH-25.995.

PMID:
20552550
6.

Prostaglandin E2 EP2 and EP4 receptor activation mediates cAMP-dependent hyperpolarization and exocytosis of renin in juxtaglomerular cells.

Friis UG, Stubbe J, Uhrenholt TR, Svenningsen P, Nüsing RM, Skøtt O, Jensen BL.

Am J Physiol Renal Physiol. 2005 Nov;289(5):F989-97. Epub 2005 Jun 28.

PMID:
15985651
7.

Prostaglandin E2 promotes wound-induced migration of intestinal subepithelial myofibroblasts via EP2, EP3, and EP4 prostanoid receptor activation.

Iwanaga K, Okada M, Murata T, Hori M, Ozaki H.

J Pharmacol Exp Ther. 2012 Mar;340(3):604-11. doi: 10.1124/jpet.111.189845. Epub 2011 Dec 2.

8.

Simultaneous stimulation of EP2 and EP4 is essential to the effect of prostaglandin E2 in chondrocyte differentiation.

Miyamoto M, Ito H, Mukai S, Kobayashi T, Yamamoto H, Kobayashi M, Maruyama T, Akiyama H, Nakamura T.

Osteoarthritis Cartilage. 2003 Sep;11(9):644-52.

9.

Role of prostaglandin E receptor subtypes EP2 and EP4 in autocrine and paracrine functions of vascular endothelial growth factor in the inner ear.

Hori R, Nakagawa T, Yamamoto N, Hamaguchi K, Ito J.

BMC Neurosci. 2010 Mar 11;11:35. doi: 10.1186/1471-2202-11-35.

10.

The role of prostaglandin E receptor subtypes (EP1, EP2, EP3, and EP4) in bone resorption: an analysis using specific agonists for the respective EPs.

Suzawa T, Miyaura C, Inada M, Maruyama T, Sugimoto Y, Ushikubi F, Ichikawa A, Narumiya S, Suda T.

Endocrinology. 2000 Apr;141(4):1554-9.

PMID:
10746663
12.

Dominant role of prostaglandin E2 EP4 receptor in furosemide-induced salt-losing tubulopathy: a model for hyperprostaglandin E syndrome/antenatal Bartter syndrome.

Nüsing RM, Treude A, Weissenberger C, Jensen B, Bek M, Wagner C, Narumiya S, Seyberth HW.

J Am Soc Nephrol. 2005 Aug;16(8):2354-62. Epub 2005 Jun 23.

13.

Expression, localization, and signaling of PGE(2) and EP2/EP4 receptors in human nonpregnant endometrium across the menstrual cycle.

Milne SA, Perchick GB, Boddy SC, Jabbour HN.

J Clin Endocrinol Metab. 2001 Sep;86(9):4453-9.

PMID:
11549693
14.
15.
16.

Role of prostaglandin E2 receptor subtypes in ovarian follicle growth in the rat in vivo. Correlation with interleukin-8 and neutrophils.

El-Nefiawy N, Abdel-Hakim K, Kanayama N, Terao T.

Histol Histopathol. 2005 Jul;20(3):825-31. doi: 10.14670/HH-20.825.

PMID:
15944932
17.

Effect of deletion of the prostaglandin EP2 receptor on the anabolic response to prostaglandin E2 and a selective EP2 receptor agonist.

Choudhary S, Alander C, Zhan P, Gao Q, Pilbeam C, Raisz L.

Prostaglandins Other Lipid Mediat. 2008 Jun;86(1-4):35-40. doi: 10.1016/j.prostaglandins.2008.02.001. Epub 2008 Feb 29.

18.

Characterization of the EP receptor subtype that mediates the inhibitory effects of prostaglandin E2 on IgE-dependent secretion from human lung mast cells.

Kay LJ, Gilbert M, Pullen N, Skerratt S, Farrington J, Seward EP, Peachell PT.

Clin Exp Allergy. 2013 Jul;43(7):741-51. doi: 10.1111/cea.12142.

PMID:
23786281
19.
20.

Supplemental Content

Support Center